Wednesday, September 15, 2021

Axios Vitals: Moderna's edge

Plus, no spike for uninsured rate during pandemic | Wednesday, September 15, 2021
 
Axios Open in app View in browser
 
Presented By UnitedHealth Group
 
Axios Vitals
By Tina Reed ·Sep 15, 2021

Good morning, Vitals readers. Today's newsletter in 824 words, or a 3-minute read.

Situational awareness: Three moderate House Democrats announced Tuesday they planned to vote against a measure in committee aimed at lowering drug prices, which is a key part of their party's massive reconciliation bill, The Hill reported.

 
 
1 big thing: Moderna and Pfizer may differ more than we thought

Illustration: Aïda Amer/Axios

 

Moderna's shot may maintain a higher effectiveness over time than Pfizer's, even though they're based on similar technology, Axios' Caitlin Owens reports.

  • The gap could always disappear with more data, and both vaccines remain very effective against severe disease.
  • But if the gap does hold up, it raises questions about whether the two vaccines should be treated the same way policy-wise.

Driving the news: Several studies have found a difference between the two vaccines' effectiveness over time, although some experts have cautioned that this could stem from flawed head-to-head comparisons.

  • "There have been sort of signals from enough separate sources that start to paint a picture that may reflect a real biological phenomenon — a real difference," said Natalie Dean, an Emery professor who specializes in vaccine study design.

Zoom in: In a study released last week, the CDC found that Moderna was significantly more effective against hospitalizations than the Pfizer or J&J vaccines.

Between the lines: Pfizer was the first vaccine authorized for use in the U.S. and began being administered several weeks before the Moderna vaccine.

  • "Because of the way the rollouts happened, the oldest and most vulnerable and sickest people, like nursing home residents, got Pfizer," said Cornell virologist John Moore.
  • However, the CDC study found that Moderna's efficacy was higher across all ages.

Yes, but: Both vaccines are nearly equal in their capacity to "do what a vaccine needs to do, which is protect against severe illness," said Paul Offit, director of the Vaccine Education Center at the Children's Hospital of Philadelphia.

The bottom line: The Moderna data may more closely resemble Pfizer's after more time passes. But it may be unwise to treat the two as if they're identical.

Go deeper.

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
2. Pandemic didn't lead to spike in uninsured
Data: Census Bureau; Chart: Axios Visuals

Roughly 8.6% of Americans didn't have health insurance in 2020, a figure that has stayed consistent since 2018, Axios' Bob Herman reports from the latest U.S. Census Bureau data.

Why it matters: Government assistance, in the form of beefed-up Medicaid eligibility and heavily subsidized plans through the Affordable Care Act, kept people insured despite the pandemic-fueled recession.

Between the lines: The Census Bureau said there was no statistically significant increase in Medicaid enrollment, but other federal data show enrollment in Medicaid and the Children's Health Insurance Program soared by 14% from February 2020 to February 2021.

  • Congress increased funds for Medicaid programs and said states couldn't kick people off Medicaid during the pandemic.
  • The Census Bureau's numbers are off from other federal data because the agency had trouble receiving responses for its survey due to the pandemic.

Reality check: While the uninsured rate didn't increase, 28 million people still didn't have health insurance.

  • And uninsured rates increased for certain subgroups, including Black children (4.6% in 2018 to 6% in 2020) and adults who live in non-expansion states (35.6% in 2018 to 38.1% in 2020).

Go deeper: Pandemic-era stimulus lifted millions out of poverty, new government data shows

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
3. Pfizer vaccine data for young kids coming in Oct.

Pfizer could release clinical trial data for the use of its COVID-19 vaccine in kids younger than 5 by the end of October, CNBC reported.

  • "Then, it is up to the FDA to take their time, and then make a decision," CEO Albert Bourla said on Tuesday, per CNBC.

Between the lines: Pfizer and BioNTech have said they expect to present results from use of COVID-vaccines in children between the ages of 5 and 11 as soon as the end of this month.

By the numbers: The news comes as the latest weekly tally of pediatric COVID-19 cases topped 243,000 infections, just shy of a record number, according to the latest report from the American Academy of Pediatrics.

  • Children made up 28.9% of all reported COVID cases in the latest data.
Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 

A message from UnitedHealth Group

Advancing health equity by addressing social determinants of health
 
 
UnitedHealth Group is committed to addressing social barriers that influence disparities in health care access, outcomes and affordability. We have helped:
  • Create 12,000 homes by investing $550 million in affordable housing.
  • Provide over 100 million meals during the pandemic.

Learn more.

 
 
4. Chart du jour
Reproduced from KFF; Chart: Axios Visuals

The surge in COVID-19 hospitalizations among the unvaccinated added up to about $5.7 billion in preventable health care costs over the summer, according to an updated KFF analysis.

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
5. Changes to Apple Watch health features
The new Apple Fitness+ program is debuted during the California Streaming virtual product launch.

Photo: Jonathan Cherry/Bloomberg via Getty Images

 

There were modest improvements and no new health sensors on the newest version of the Apple Watch, which debuted Tuesday during a virtual event.

Between the lines: As the Wall Street Journal reported earlier this month, Apple is working on health-related features for its smart watch, such as a blood pressure sensor and a thermometer for fertility planning.

  • But analysts have said most of Apple's "more ambitious health-related improvements aren't expected before 2022" with a future version of the watch, per WSJ. 
  • The biggest health-related announcements for Apple Watch Series 7 instead centered around the expansion of Apple Fitness+, which is Apple's workout streaming subscription program. They also debuted fall detection for cyclists, as well as a new mindfulness app.
Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
6. Business notes
  • Delta Air Lines says its $200 monthly healthcare surcharge motivated one-fifth of its unvaccinated workers to get vaccinated against COVID-19 within two weeks. (Business Insider)
  • Aetna is being sued over fertility treatment coverage for LGBTQ people. (NBC News)
  • Amazon's bet on healthcare begins to take shape. (Financial Times)
  • The DOJ says a data mining company fabricated medical diagnoses to make money. (NPR)
Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 

A message from UnitedHealth Group

Expanding access to care in underserved communities
 
 

UnitedHealth Group is helping to address social determinants of health for uninsured individuals and underserved communities.

See how we're advancing health equity through community partnerships that have helped more than 6 million people access care, nutritious food and stable housing.

 
HQ
Like this email style and format? Learn more about Axios HQ.
It'll help you deliver employee communications more effectively.
 

Axios thanks our partners for supporting our newsletters. If you're interested in advertising, learn more here.
Sponsorship has no influence on editorial content.

Axios, 3100 Clarendon B‌lvd, Suite 1300, Arlington VA 22201
 
You received this email because you signed up for newsletters from Axios.
Change your preferences or unsubscribe here.
 
Was this email forwarded to you?
Sign up now to get Axios in your inbox.
 

Follow Axios on social media:

Axios on Facebook Axios on Twitter Axios on Instagram
 
 
                                             

No comments:

Post a Comment

News template

...